Skip to main content

Artificial Intelligence (AI) in Neurology Operating Room Market is expected to grow at a CAGR of 49.69% by 2030

 

AI in Neurology Operating Room

BIS Research defines AI in neurology operating room as a sub-segment of the overall healthcare system wherein algorithms, software, and AI-enabled devices are used for augmenting the neurosurgical process, data management, diagnosis, and rehabilitation, among other operations which are limited to the operation theater.

The impact on AI adoption in operating rooms was low-moderate due to the fact that the global AI in neurology operating room market is in the early stage of commercialization and has been witnessing strong growth in terms of market value.

The global artificial intelligence (AI) in neurology operating room market is expected to grow at a CAGR of 49.69% during the forecast period, 2021-2030.

Many players in the global AI in operating room market have products and solutions which cater to applications such as scheduling, diagnosis, training, and instrument tracking for most of the indications. However, with time, new market entrants are expected to target niche applications and indications. Given the nature and the early phase of developments in the market, many companies have products in the pipeline, and more new players can be continuing their research and development in stealth mode.

The global AI in neurology operating room market is expected to witness tremendous growth during the forecast period 2021-2030, registering a CAGR of XX%. Leading companies in the market aim to maintain a competitive advantage with a strong global presence and advanced product portfolio.

The concept of artificial intelligence in the operating room is not a new concept. However, products have been commercialized only since 2018. Thus, most of the companies in the market have been involved in funding activities in recent years.

AI-based software used in operating rooms is rigorously trained by using numerous datasets and images that are then used for various applications, including identification of image patterns, improvement of workflow, image analysis, decision support, remote monitoring, predictive analysis, and reporting and communication.

The purpose of the study is to enable the reader to gain a holistic view of the global AI in neurology operating room market by each of the aforementioned segments. 

The report constitutes an in-depth analysis of the global AI in neurology operating room market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers software solutions and hardware solutions integrated with AI.

Request a Sample - https://bisresearch.com/requestsample?id=1118&type=download 


Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more